Amate Medical Secures Over RMB 200 Million in Series D Funding and Advances Toward Hong Kong IPO as a Rising Star in Domestic Pan-Vascular Intervention
AMT Medical Inc.
3D-Printed Vascular Stent Technology Developer
Recently, there is another significant positive development in the track of high-end implantable and interventional devices produced in China:Beijing AMT Medical Inc. Completes Over 200 Million Yuan in D-Round Financing, Post-Investment Valuation Exceeds 1.5 Billion YuanLed by Zhejiang Synergistic Life Health Fund, with participation from Henan Key Intellectual Property Fund, Global Hedge Fund and other institutions.
Notably, in addition to the successful financing, thisHolding China's first Class III CO2 contrast injection product registration certificate, and being the world's only company to achieve fully bioresorbable stents for both coronary and peripheral applications.The company entering clinical trials submitted an application to the Hong Kong Stock Exchange last year and received approval for overseas listing from the CSRC.Expected to officially list on the Hong Kong Stock Exchange in the second half of this year, is expected to become "the first domestically-produced pan-vascular interventional stock in China."
Why AMT Medical Inc.?
Hardcore technology is the confidence to win capital bets
Under the centralized procurement, the profit of traditional consumables has been compressed to the freezing point. However, innovative products with exclusive technologies that fill clinical gaps have stood their ground in the fierce market competition due to their scarcity and essential demand. AMT Medical Inc. is the most representative potential target.
For a long time, the global degradable stent market has been firmly monopolized by giants such as Abbott and Boston Scientific using laser cutting technology, making it difficult for Chinese-produced enterprises to break through. However, AMT Medical Inc. has taken a completely independent and differentiated route:
Unique 3D-MAP Multi-Axis Precision Printing Technology:颠覆传统减材制造，一步成型无废料，材料利用率提升数倍，更能制造传统工艺无法实现的复杂支架结构，Adhesion, support force, and endothelialization speed are all leading, completely bypassing core overseas patents.
Self-developed PLCL Medical Biodegradable Material:Lead the National "Challenge Project",Achieving a balance between molecular-level rigidity and flexibility, with non-toxic degradation products and clear metabolism, breaking away from the dependence on imported materials at the source
AMT Medical Inc.'s product portfolio fills critical gaps in clinical needs with each offering.
Starfall Rain ® Carbon Dioxide Contrast Device:Officially approved by NMPA in April 2026, it isChina's first approved Class III CO₂ contrast injection product, with no renal toxicity and no risk of iodine allergy., perfectly solving the imaging challenges for high-risk patients with renal insufficiency, iodine contrast agent allergies, and hyperthyroidism. It has been sold in over 20 countries overseas, and after receiving approval in China, it is about to welcome its first year of increased sales.
Biodegradable Stent Pipeline:The world's only fully biodegradable coronary and peripheral stentsCompanies entering clinical trials: Coronary stents with zero thrombosis after 6 years of follow-up, long-term safety reaching internationally top-tier levels; two products have entered the National Innovative Medical Device Special Approval Channel.
Survival Rules in the Midst of Industry Restructuring
Choosing the right innovation track is more important than working hard blindly!!
It is worth mentioning that, like all research and development-oriented medical device companies, AMT Medical Inc.'s commercialization is still in its growth phase and may struggle to achieve profitability in the short term. However, this successful round of financing also confirms that:Focusing on clinical needs and innovative tracks with exclusive barriers is the current trend in China's medical device development.
But we deeply understand that the vast majority of dealer friends are stuck at the most awkward crossroads:
✅ Traditional consumables profits have been slashed by centralized procurement to the floor, selling more but earning less, or even losing money for publicity.
✅ Want to transition to an innovative track, but troubled by the information gap, can't tell which are true blue oceans and which are pseudo-concepts.
✅ Can't understand the technical barriers of the product, don't know which ones can be profitable in the long term and which ones are just fleeting.
✅ When others have already made a fortune, you only hear about this track then. Entering the market means you can only drink the leftover soup or even step into pitfalls.
Many innovative medical device markets worth hundreds of millions, many distributors don't even think about early layout, and may not even pay attention to the listing news. However, those who got the information earlier and chose the right products are already enjoying the high gross profit dividends brought by technological barriers.
Break the Information Barrier!
This White Paper Helps You Identify the Next Big Hit
In order to help a wide range of medical device distributorsBreaking Industry Information Barriers, Precisely Targeting High-Profit Tracks in Innovative Medical Devices, comprehensively grasp the core opportunities in the industry's development, we have heavily built and launched"Breaking Boundaries, Leading the Way: White Paper on China's Medical Device Innovation in a Global Context"
This book not onlyProvided a comprehensive overview of nearly 400 innovative products globally and in China, and also conducted an in-depth analysis of 72+ product benchmark cases across 16 major medical device sectors., an innovative navigation map specifically designed for medical device distributors/agents/companies.
The First White Paper on Innovative Medical Devices in the Industry
Original Price: 499 RMB
Special Promotion Event for Customer Appreciation
Only 269 yuan!!!
?Click on the image for more details?
*Advertisement
White PaperFocusing on cardiovascular intervention, surgical robots, medical imaging, tumor ablation, orthopedics, endoscopy, and novel medical materials.16 High-Growth Popular Tracks, Selecting innovative products, detailed from point to surfaceExplain the market status, technology trends, and competitive landscape to help dealers accurately grasp the market pulse.
Taking the currently most popular surgical robot as an example, the white paper not only introduces the mainstream products currently on the market, but alsoIn-depth analysis of the technical characteristics, clinical application effects, and market strategies of each brand.By comparative analysis, dealers can clearly see the strengths and weaknesses of different products, thereby making more informed choices.
Innovation White PaperDisplay of the Inner Pages of the Book
In "Pseudo-Innovation”In a market environment with a wide range of products, the panoramic product overview function of the white paper becomes particularly important.
It not only lists 75 innovative medical device products globally and 315 innovative medical device products in China, but also fromPolicy Support, Market Prospects, Core Technology, Clinical Application, Competitive Landscape, Manufacturer Strengthfrom multiple dimensions for a comprehensive evaluation. Breaking down information barriers, reducing information asymmetry, and helping medical device distributors deeply and comprehensively understand the innovative medical device products currently available on the market.
For example, in the field of cardiovascular interventionThe white paper provides a detailed comparison of heart stent products from different brands, including their materials, design, clinical outcomes, pricing, and manufacturers' production line information, offering distributors an objective and comprehensive reference.。
The First White Paper on Innovative Medical Devices in the Industry
Original Price: 499 RMB
Special Promotion Event for Customer Appreciation
Only 269 RMB!!!
?Click on the image for more details?
Display of Partial Table of Contents of the White Paper
Setting the Course for the Next Decade, Seizing Strategic Market High Ground
The white paper not only analyzes the market based on the current situation but also takes a global perspective.From multiple dimensions such as industrial development, clinical application, multidisciplinary integration, the rise of domestically produced products, and cutting-edge research, in-depth analysis of the five major development trends of innovative medical devices in the next decade, such asThe application prospects of emerging technologies such as artificial intelligence, big data, and 3D printing in the medical device field, as well as the impact of social factors like population aging and the increase in chronic diseases on market demand.
At the same time, the white paper also provides an in-depth analysis of six popular细分 markets, offering interpretations of fields such as AI healthcare, minimally invasive interventions, regenerative medicine, digital therapeutics, intelligent rehabilitation, and medical robotics. This guides distributors to identify niche market opportunities, helping them focus on the present while planning for the future.
Overview of Support Policies Across China, Accurately Grasping Industry Trends
Innovative medical device support policies, from a top-level design perspective, represent the country's supportive stance towards the development of innovative medical devices.This has also impacted the level of support for innovative healthcare from the National Health Commission and the National Healthcare Security Administration down to hospitals at all levels.From the perspective of implementation, innovations in medical devices, DRG exclusions, and expedited hospital entry pathways significantly impact hospital admissions.
Innovation White PaperIn-depth analysis of the support policies for innovative medical devices by the central government and provinces across China over the past three years,Covering everything from top-level design, financial support to market access,Help medical device distributors gain early insights into policy trends.
A comprehensive grasp of the national and provincial support policies for innovative medical devices in China is the key to understanding the direction of industry development and the crucial factor for promoting products in hospitals.
In this innovation-driven new era, only those distributors who can accurately grasp policy directions, gain insights into market trends, and precisely select products will be able to remain invincible in fierce competition.
Innovation is no longer just a decorative add-on but a mandatory course and survival skill for distributors.Let us take "Breaking Boundaries, Leading the Way" as our guideSouth, setting sail in the wave of innovation, seizing the opportunity, and ushering in a new era of medical device distribution!
The First White Paper on Innovative Medical Devices in the Industry
Original Price: 499 RMB
Special Promotion Event for Customer Appreciation
Only 269 yuan!!!
?Click on the image for more details?
*Advertisement